Tag: Kimmtrak

Home / Kimmtrak

Categories

Tebentafusp-tebn is approved for unresectable or metastatic uveal melanoma

March 2022: Tebentafusp-tebn (Kimmtrak, Immunocore Limited), a bispecific gp100 peptide-HLA-directed CD3 T cell engager, has been licenced by the Food and Drug Administration for HLA-A*02:01-positive ...
kimmtrak

We Are Online! Chat With Us!
Scan the code